Tech Stocks Bouncing Back
On Monday, we learned Novartis is in talks to buy Cytokinetics, the maker of a promising cardiovascular drug.
Source: forbes.com
Higher So Far This News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Higher So Far This. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Higher So Far This Today - Breaking & Trending Today